Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations

D Miki, M Kubo, A Takahashi, KA Yoon, J Kim, GK Lee… - Nature …, 2010 - nature.com
… that modify the risk of lung adenocarcinoma, we conducted a … a Japanese cohort, with
replication in two independent studies in Japanese and Korean individuals, in a total of 2,098 lung

Differences in the prognosis of resected lung adenocarcinoma according to the histological subtype: a retrospective analysis of Japanese lung cancer registry data

H Sakurai, H Asamura, E Miyaoka… - European Journal of …, 2014 - academic.oup.com
… features of histological subtypes of lung adenocarcinoma based on the 1999 WHO … histological
subtype of lung adenocarcinoma because most lung adenocarcinomas are histologically …

[HTML][HTML] Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201

…, Japan Clinical Oncology Group Lung Cancer … - The Journal of thoracic …, 2013 - Elsevier
… has greatly progressed.1, 2, 3, 4, 5 This understanding is reflected in the recently revised
international multidisciplinary classification of lung adenocarcinoma sponsored by the …

[HTML][HTML] Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma

T Kosaka, Y Yatabe, R Onozato, H Kuwano… - Journal of Thoracic …, 2009 - Elsevier
… , never smokers, patients of Asian ethnicity, and those with histology of adenocarcinoma
8 . We previously showed that about 50% of lung adenocarcinomas from Japanese patients

[HTML][HTML] Clinicopathologic and genotypic features of lung adenocarcinoma characterized by the international association for the study of lung cancer grading system

R Fujikawa, Y Muraoka, J Kashima, Y Yoshida… - Journal of Thoracic …, 2022 - Elsevier
… Our findings suggest that the grading system clinicopathologically and biologically defines
characteristic subsets of operable lung adenocarcinoma. Using preoperative variables of …

[HTML][HTML] … significance of cribriform adenocarcinoma of the lung: validation analysis of 1,057 Japanese patients with resected lung adenocarcinoma and a review of the …

N Nakajima, A Yoshizawa… - Translational Lung …, 2021 - ncbi.nlm.nih.gov
… of a series of 1,057 Japanese patients with resected lung adenocarcinoma to identify the …
Our results indicate that Cribri-ADC is the unfavorable lung adenocarcinoma subgroup in terms …

[HTML][HTML] … IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients

A Yoshizawa, S Sumiyoshi, M Sonobe… - Journal of Thoracic …, 2013 - Elsevier
… subtypes of lung adenocarcinomas among Japanese patients. Histologic subtyping and
molecular testing for EGFR and KRAS mutations can help predict patient prognosis and select …

[HTML][HTML] Frequency of EGFR and KRAS mutations in Japanese patients with lung adenocarcinoma with features of the mucinous subtype of bronchioloalveolar …

A Hata, N Katakami, S Fujita, R Kaji, Y Imai… - Journal of thoracic …, 2010 - Elsevier
… One hundred ninety-one patients with adenocarcinoma of the lung underwent surgery at our
institution. There were 59 patients (30%) diagnosed with BAC/AWBF; 20 had MBAC/AWBF (…

[HTML][HTML] Correlation between HLA alleles and EGFR mutation in Japanese patients with adenocarcinoma of the lung

H Uramoto, T So, Y Nagata, K Kuroda… - Journal of Thoracic …, 2010 - Elsevier
… was obtained either from all the patients or from the patient's legal guardians. Tumor samples
were obtained from 623 patients with primary lung adenocarcinoma who had undergone a …

Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma

T Iuchi, M Shingyoji, T Sakaida, K Hatano, O Nagano… - Lung cancer, 2013 - Elsevier
… in cognitive function of patients. In this study, we evaluated the efficacy of gefitinib alone
without radiation therapy for the treatment of patients with BM from lung adenocarcinoma. …